Sustainability 2010 Goals

After conferring with hundreds of internal and external stakeholders, Bristol-Myers Squibb adopted long-term, comprehensive sustainability goals for 2010. We track our performance against these goals worldwide and report to the public on our progress, whether negative or positive. We strive to make our company more sustainable by meeting, and where possible, exceeding these goals.

"At Technical Operations, sustainability is an integral part of our global manufacturing strategy that drives our vision to become the highest quality, most reliable and admired supply organization in the pharmaceutical industry. Our employees are committed to helping patients prevail by supplying the company's innovative medicines to patients with serious diseases while upholding the highest levels of safety, quality and compliance with worldwide regulations. We are building new facilities and enhancing our existing facilities using the latest thinking and technologies that incorporate environmental, safety and energy efficiencies. Through our Sustainability 2010 Goals, we have been successful in reducing our energy and water consumption, and we continue to enhance our manufacturing processes to the benefit of the environment, our operational efficiency and the communities in which we operate."

Carlo de Notaristefani
President, Technical Operations, Bristol-Myers Squibb

2010 Goals - Progress Report

The table below presents the company's status in meeting the Sustainability 2010 Goals. These goals were developed in 2000 as stretch goals for our company, and we continue to work toward achieving all of these goals by the end of 2010, although the pace of progress differs by goal. The completion status data provided below was determined through reviews of progress to date by Bristol-Myers Squibb executives and a third-party evaluation of each goal.
Use the links in this report card to find more detailed information about the goals.




2010 Goal

Examples of Progress and Completion Status

EHS effects analysis conducted by all manufacturing, research and development, and distribution facilities to identify their most significant EHS impacts and opportunities for improvement

  • Conducted EHS effects analysis at all major Bristol-Myers Squibb facilities.

EHS research contributions through the Bristol-Myers Squibb Foundation and other sources to demonstrate the company's commitment to expand society's knowledge and understanding.

  • Funded biodiversity mapping of Puerto Rico and helped develop ecoregional plan and educational tools with The Nature Conservancy.
  • Supported Environmental Associates “Know Your Environment” publication.

Facility-level community outreach to enhance communications with neighbors on EHS and sustainability topics.

 

  • Published facility and companywide information on EHS/sustainability Internet site
  • Incorporated EHS/sustainability information into annual Company Overview presentation.
  • Increased engagement with socially responsible organizations.
  • The Corporate Responsibility Officer CRO Magazine ranked Bristol-Myers Squibb number one on its annual 100 Best Corporate Citizens list for 2009.
  • Earned CERES Award in 2007 for 2nd place Best Sustainability Report.

Land preservation of biologically diverse land to offset the property used by Bristol-Myers Squibb's total operations worldwide and to promote employee participation in protecting critical land areas.

 

  • Funded conservation of 1,616 hectares of biologically diverse
    habitat in 8 countries, which fully offsets the 2000 BMS footprint of worldwide operations.

Leadership development program to enhance EHS integration throughout the company.

 

  • Incorporated EHS and sustainability examples into Core Behaviors training and testing.
  • Developed EHS/sustainability orientation brochure for new executives.
  • Developed EHS/sustainability posters, brochure, website and training presentations.
  • Conducted EHS coordinator orientation workshops.
  • Held global, cross-functional EHS leadership conference.

Environmental performance targets and goals (normalized by sales)

  • Reduce energy use by 10 percent from 2001 baseline year.
  • Reduce water use by 10 percent from 2001 baseline year. In countries where water resources are severely stressed, reduce absolute water use by 20 percent from 2002 baseline year.
  • Reduce total greenhouse gas emissions (e.g., carbon dioxide and methane) by 10 percent from 2001 baseline year.
  • Reduce nonhazardous waste by 20 percent from 2002 baseline year. Reduce off-site hazardous waste disposal by 50 percent from 2001 baseline year.
  • Reduce air emissions of acid gases (sulfur oxides, nitrogen oxides, and hydrogen chloride) by 10 percent from 2003 baseline year.
  • Reduce off-site release to air of priority reduction chemicals by 50 percent from 2002 baseline year.
  • Reduce wastewater releases of total chemical oxygen demand, suspended solids, and nitrates by 10 percent from 2002 baseline.
  • Developed systems for establishing baselines and aggregating annual environmental data across the enterprise.
  • Deployed prioritized facility goal implementation strategies.
  • Met all goals to date except water use from stressed areas and biodiversity goals.

Key Performance Indicator

Baseline Year

Baseline Data

2008 Data

Baseline Year - 2008 Data (% Change)

2010 Goal (%)

2010 Goal (Value)

Energy use

Total energy
use, direct and
indirect (megaJoules/
$1,000 sales)

2001

1,297

784

-40%

-10%

1,167

Air emissions

Total greenhouse gas emissions (kg/$1,000 sales)

2001

70.9

43.1

-39%

-10%

63.8

Air emission of priority reduction chemicals (kg/$1,000 sales)

2002

0.15

0.06

-60%

-50%

0.07

Acid gas
emissions
(NOx, SOx,
HCl)
(g/$1,000 sales)

2003

33.5

15

-54%

-10%

30.2

Waste

Hazardous
waste off-site
treatment/
disposal
(kg/$1,000
sales)

2001

0.51

0.17

-67%

-50%

0.25

Nonhazardous waste disposed (kg/$1,000 sales)

2002

2.55

1.41

-45%

-20%

2.04

Water Use

Water use (liters/$1,000
sales)

2001

2,330

1,482

-36%

-10%

2,097

Water use from stressed areas* (percent of
countries
achieving goal)

2002

0

83%

83%

100%

6 countries

Effluents to Water

Discharge of
general pollutants (g/$1,000 sales)

2002

228

117

-49%

-10%

205

Biodiversity

Endangered
and Threatened Species Adoption

2000

0

16 countries and U.S. states and Puerto Rico

73%

100%

22 countries and U.S. states and Puerto Rico

Land Preservation

Biologically
diverse land preservation (hectares)

2000

1,336

1,616

102%

100%

1,589

* The 2010 goal for water use from stressed areas has changed due to plant closure.

Biotechnology development.

 

  • Developed system to review and address in-licensed products.
  • Implemented program to ensure third-party manufacturers comply with company and regulatory biosafety requirements.
  • Implemented program to conduct risk assessments of regulated materials.
  • Formed bioethics committee, responsible for issuing global policies and implementing training.

EHS research sponsored by the company for early study of emerging areas of concern.

 

  • Supported research on pharmaceuticals in the environment and other key issues through Pharmaceutical Research and Manufacturers of America.
  • Supported development of “Greener Hospitals:  Improving Environmental Performance” manual and “Handling Cyctostatic Drugs” monograph

Social policies and metrics to raise corporate awareness of emerging social issues.

 

  • Benchmarked social issues and relayed emerging issues to appropriate functions.
  • Established a privacy policy.
  • Adopted direct-to-consumer communications code.
  • Committed to one-year delay in advertising new pharmaceutical products directly to consumers.
  • Committed to clinical trial disclosure.
  • Developed policy to improve access to HIV/AIDS medicines through non-enforcement of patent in sub-Saharan Africa and through process technology transfer.
  • Implemented access to medicines programs in the U.S.

Supply chain partnership to promote EHS performance improvements among key suppliers.

 

  • Issued third-party manufacturer directive.
  • Established program for ongoing EHS assessments of third-party manufacturers.
  • Benchmarked program through Pharmaceutical Supply Chain initiative.
  • Piloted Green Supplier Network with peer companies.
  • Participated in Mexico CEC NAFTA Competitive Chains supplier program.

Sustainable products promotion through packaging reductions, green chemistry, and inherent product and process safety. Develop companywide metrics to track progress on key product, process, and packaging initiatives.

 

  • Developed and deployed green chemistry scorecard.
  • Implemented green chemistry evaluations of in-licensed products.
  • Developed process safety directive and conducted global training.
  • Reduced PVC from packaging components.
  • Established Sustainable Packaging Committee

Endangered species sponsorship to encourage each facility and business to help protect local endangered species and habitats.

 

  • Protected species through programs sponsored by facilities in 16 out of 22 countries, U.S. states and Puerto Rico.

Sustainability awards promote sustainability behavior among employees across the company.

 

  • Developed a draft proposal for award program.

Safety performance - Reduce recordable and lost workday case rates by 50% based on 2000 base year. Maintain performance in top 25% of similar companies.

 

  • Established annual business targets, action plans, accountability and performance reporting.
  • Promoted prevention activities through focus on at-risk behaviors, bulletins, public relations campaign and driver safety training.
  • Achieved U.S. OSHA Voluntary Protection Program status at facilities in Evansville and Mt. Vernon, Indiana.

Key Performance Indicator

Baseline Year

Baseline Performance

2008 Data

Baseline Year - 2008 Performance (% Change)

2010 Goal (%)

2010 Goal (Value)

Health and Safety

Recordable case rate (cases/100 employees)

2000

1.3

0.72

-45%

-50%

0.65

Recordable case rate performance compared to similar companies*

--

--

Top 25%

--

Top 25%

--

Lost workday case rate (cases/100 employees)

2000

0.34

0.26

-24%

-50%

0.17

Lost workday case rate performance compared to similar companies*

--

--

Top 50%

--

Top 25%

--

*Based on 2007 data (most recently available)